Protein amyloids develop an intrinsic fluorescence signature during aggregation

Analyst. 2013 Apr 7;138(7):2156-62. doi: 10.1039/c3an36798c. Epub 2013 Feb 18.

Abstract

We report observations of an intrinsic fluorescence in the visible range, which develops during the aggregation of a range of polypeptides, including the disease-related human peptides amyloid-β(1-40) and (1-42), lysozyme and tau. Characteristic fluorescence properties such as the emission lifetime and spectra were determined experimentally. This intrinsic fluorescence is independent of the presence of aromatic side-chain residues within the polypeptide structure. Rather, it appears to result from electronic levels that become available when the polypeptide chain folds into a cross-β sheet scaffold similar to what has been reported to take place in crystals. We use these findings to quantify protein aggregation in vitro by fluorescence imaging in a label-free manner.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid / chemistry*
  • Amyloid beta-Peptides / chemistry*
  • Fluorescence*
  • Humans
  • Muramidase / chemistry*
  • Peptide Fragments / chemistry*
  • Protein Structure, Secondary
  • Protein Structure, Tertiary*
  • tau Proteins / chemistry*

Substances

  • Amyloid
  • Amyloid beta-Peptides
  • MAPT protein, human
  • Peptide Fragments
  • amyloid beta-protein (1-40)
  • amyloid beta-protein (1-42)
  • tau Proteins
  • Muramidase